Xgen Pharms Company Profile
✉ Email this page to a colleague
What is the competitive landscape for XGEN PHARMS, and what generic and branded alternatives to XGEN PHARMS drugs are available?
XGEN PHARMS has eighteen approved drugs.
Summary for Xgen Pharms
| US Patents: | 0 |
| Tradenames: | 17 |
| Ingredients: | 17 |
| NDAs: | 18 |
Drugs and US Patents for Xgen Pharms
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Xgen Pharms | LINCOMYCIN HYDROCHLORIDE | lincomycin hydrochloride | INJECTABLE;INJECTION | 201746-001 | Jun 4, 2015 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Xgen Pharms | FOLIC ACID | folic acid | INJECTABLE;INJECTION | 202522-001 | Nov 6, 2019 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Xgen Pharms | CYCLOPHOSPHAMIDE | cyclophosphamide | INJECTABLE;INJECTION | 211757-003 | Oct 18, 2022 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Xgen Pharms | DACTINOMYCIN | dactinomycin | INJECTABLE;INJECTION | 203999-001 | May 20, 2019 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Xgen Pharms | AMPHOTERICIN B | amphotericin b | INJECTABLE;INJECTION | 063206-001 | Apr 29, 1992 | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | |||||
| Xgen Pharms | LEVETIRACETAM | levetiracetam | INJECTABLE;INTRAVENOUS | 091485-001 | Aug 5, 2011 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
